Global Cryptococcosis Drugs Market Growth (Status and Outlook) 2025-2031

December 2025 | 86 pages | ID: GC4FDBAC9E3EN
LP Information

Abstracts

According to this study, the global Cryptococcosis Drugs market size will reach US$ million by 2031.

Cryptococcosis is a fungal disease.It is caused by Cryptococcus neococcus, or Cryptococcus gattii.The disease is spread by inhaling a fungus linked to birds.It can infect animals and humans.It infects humans by inhaling fungus.The fungus mainly affects the lungs, but it can spread to the brain, called meningitis.Symptoms of the disease include - fever, headache, fatigue, dry cough and blurred vision.It can be treated by dozing off with amphotericin B, fluorocytosine and fluconazole.

United States market for Cryptococcosis Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cryptococcosis Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cryptococcosis Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cryptococcosis Drugs players cover Abbott, Pfizer, Bristol-Mayers Squibb, Sigmapharm Laboratories, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Cryptococcosis Drugs Industry Forecast” looks at past sales and reviews total world Cryptococcosis Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Cryptococcosis Drugs sales for 2025 through 2031. With Cryptococcosis Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cryptococcosis Drugs industry.

This Insight Report provides a comprehensive analysis of the global Cryptococcosis Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cryptococcosis Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cryptococcosis Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cryptococcosis Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cryptococcosis Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Cryptococcosis Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Amphotericin B
• Flucytosine
• Fluconazole
• Others

Segmentation by Application:

• Hospital Pharmacy
• Retail Pharmacies
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott
• Pfizer
• Bristol-Mayers Squibb
• Sigmapharm Laboratories
• Novartis
• Glenmark Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cryptococcosis Drugs Market Size (2020-2031)
  2.1.2 Cryptococcosis Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Cryptococcosis Drugs by Country/Region (2020, 2024 & 2031)
2.2 Cryptococcosis Drugs Segment by Type
  2.2.1 Amphotericin B
  2.2.2 Flucytosine
  2.2.3 Fluconazole
  2.2.4 Others
2.3 Cryptococcosis Drugs Market Size by Type
  2.3.1 Cryptococcosis Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Cryptococcosis Drugs Market Size Market Share by Type (2020-2025)
2.4 Cryptococcosis Drugs Segment by Application
  2.4.1 Hospital Pharmacy
  2.4.2 Retail Pharmacies
  2.4.3 Other
2.5 Cryptococcosis Drugs Market Size by Application
  2.5.1 Cryptococcosis Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Cryptococcosis Drugs Market Size Market Share by Application (2020-2025)

3 CRYPTOCOCCOSIS DRUGS MARKET SIZE BY PLAYER

3.1 Cryptococcosis Drugs Market Size Market Share by Player
  3.1.1 Global Cryptococcosis Drugs Revenue by Player (2020-2025)
  3.1.2 Global Cryptococcosis Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Cryptococcosis Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CRYPTOCOCCOSIS DRUGS BY REGION

4.1 Cryptococcosis Drugs Market Size by Region (2020-2025)
4.2 Global Cryptococcosis Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cryptococcosis Drugs Market Size Growth (2020-2025)
4.4 APAC Cryptococcosis Drugs Market Size Growth (2020-2025)
4.5 Europe Cryptococcosis Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Cryptococcosis Drugs Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Cryptococcosis Drugs Market Size by Country (2020-2025)
5.2 Americas Cryptococcosis Drugs Market Size by Type (2020-2025)
5.3 Americas Cryptococcosis Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cryptococcosis Drugs Market Size by Region (2020-2025)
6.2 APAC Cryptococcosis Drugs Market Size by Type (2020-2025)
6.3 APAC Cryptococcosis Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cryptococcosis Drugs Market Size by Country (2020-2025)
7.2 Europe Cryptococcosis Drugs Market Size by Type (2020-2025)
7.3 Europe Cryptococcosis Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cryptococcosis Drugs by Region (2020-2025)
8.2 Middle East & Africa Cryptococcosis Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Cryptococcosis Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CRYPTOCOCCOSIS DRUGS MARKET FORECAST

10.1 Global Cryptococcosis Drugs Forecast by Region (2026-2031)
  10.1.1 Global Cryptococcosis Drugs Forecast by Region (2026-2031)
  10.1.2 Americas Cryptococcosis Drugs Forecast
  10.1.3 APAC Cryptococcosis Drugs Forecast
  10.1.4 Europe Cryptococcosis Drugs Forecast
  10.1.5 Middle East & Africa Cryptococcosis Drugs Forecast
10.2 Americas Cryptococcosis Drugs Forecast by Country (2026-2031)
  10.2.1 United States Market Cryptococcosis Drugs Forecast
  10.2.2 Canada Market Cryptococcosis Drugs Forecast
  10.2.3 Mexico Market Cryptococcosis Drugs Forecast
  10.2.4 Brazil Market Cryptococcosis Drugs Forecast
10.3 APAC Cryptococcosis Drugs Forecast by Region (2026-2031)
  10.3.1 China Cryptococcosis Drugs Market Forecast
  10.3.2 Japan Market Cryptococcosis Drugs Forecast
  10.3.3 Korea Market Cryptococcosis Drugs Forecast
  10.3.4 Southeast Asia Market Cryptococcosis Drugs Forecast
  10.3.5 India Market Cryptococcosis Drugs Forecast
  10.3.6 Australia Market Cryptococcosis Drugs Forecast
10.4 Europe Cryptococcosis Drugs Forecast by Country (2026-2031)
  10.4.1 Germany Market Cryptococcosis Drugs Forecast
  10.4.2 France Market Cryptococcosis Drugs Forecast
  10.4.3 UK Market Cryptococcosis Drugs Forecast
  10.4.4 Italy Market Cryptococcosis Drugs Forecast
  10.4.5 Russia Market Cryptococcosis Drugs Forecast
10.5 Middle East & Africa Cryptococcosis Drugs Forecast by Region (2026-2031)
  10.5.1 Egypt Market Cryptococcosis Drugs Forecast
  10.5.2 South Africa Market Cryptococcosis Drugs Forecast
  10.5.3 Israel Market Cryptococcosis Drugs Forecast
  10.5.4 Turkey Market Cryptococcosis Drugs Forecast
10.6 Global Cryptococcosis Drugs Forecast by Type (2026-2031)
10.7 Global Cryptococcosis Drugs Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Cryptococcosis Drugs Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott
  11.1.1 Abbott Company Information
  11.1.2 Abbott Cryptococcosis Drugs Product Offered
  11.1.3 Abbott Cryptococcosis Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbott Main Business Overview
  11.1.5 Abbott Latest Developments
11.2 Pfizer
  11.2.1 Pfizer Company Information
  11.2.2 Pfizer Cryptococcosis Drugs Product Offered
  11.2.3 Pfizer Cryptococcosis Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Pfizer Main Business Overview
  11.2.5 Pfizer Latest Developments
11.3 Bristol-Mayers Squibb
  11.3.1 Bristol-Mayers Squibb Company Information
  11.3.2 Bristol-Mayers Squibb Cryptococcosis Drugs Product Offered
  11.3.3 Bristol-Mayers Squibb Cryptococcosis Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bristol-Mayers Squibb Main Business Overview
  11.3.5 Bristol-Mayers Squibb Latest Developments
11.4 Sigmapharm Laboratories
  11.4.1 Sigmapharm Laboratories Company Information
  11.4.2 Sigmapharm Laboratories Cryptococcosis Drugs Product Offered
  11.4.3 Sigmapharm Laboratories Cryptococcosis Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Sigmapharm Laboratories Main Business Overview
  11.4.5 Sigmapharm Laboratories Latest Developments
11.5 Novartis
  11.5.1 Novartis Company Information
  11.5.2 Novartis Cryptococcosis Drugs Product Offered
  11.5.3 Novartis Cryptococcosis Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Novartis Main Business Overview
  11.5.5 Novartis Latest Developments
11.6 Glenmark Pharmaceuticals
  11.6.1 Glenmark Pharmaceuticals Company Information
  11.6.2 Glenmark Pharmaceuticals Cryptococcosis Drugs Product Offered
  11.6.3 Glenmark Pharmaceuticals Cryptococcosis Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Glenmark Pharmaceuticals Main Business Overview
  11.6.5 Glenmark Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cryptococcosis Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Cryptococcosis Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Amphotericin B
Table 4. Major Players of Flucytosine
Table 5. Major Players of Fluconazole
Table 6. Major Players of Others
Table 7. Cryptococcosis Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Cryptococcosis Drugs Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Cryptococcosis Drugs Market Size Market Share by Type (2020-2025)
Table 10. Cryptococcosis Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Cryptococcosis Drugs Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Cryptococcosis Drugs Market Size Market Share by Application (2020-2025)
Table 13. Global Cryptococcosis Drugs Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Cryptococcosis Drugs Revenue Market Share by Player (2020-2025)
Table 15. Cryptococcosis Drugs Key Players Head office and Products Offered
Table 16. Cryptococcosis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Cryptococcosis Drugs Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Cryptococcosis Drugs Market Size Market Share by Region (2020-2025)
Table 21. Global Cryptococcosis Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Cryptococcosis Drugs Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Cryptococcosis Drugs Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Cryptococcosis Drugs Market Size Market Share by Country (2020-2025)
Table 25. Americas Cryptococcosis Drugs Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Cryptococcosis Drugs Market Size Market Share by Type (2020-2025)
Table 27. Americas Cryptococcosis Drugs Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Cryptococcosis Drugs Market Size Market Share by Application (2020-2025)
Table 29. APAC Cryptococcosis Drugs Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Cryptococcosis Drugs Market Size Market Share by Region (2020-2025)
Table 31. APAC Cryptococcosis Drugs Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Cryptococcosis Drugs Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Cryptococcosis Drugs Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Cryptococcosis Drugs Market Size Market Share by Country (2020-2025)
Table 35. Europe Cryptococcosis Drugs Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Cryptococcosis Drugs Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Cryptococcosis Drugs Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Cryptococcosis Drugs Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Cryptococcosis Drugs Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Cryptococcosis Drugs
Table 41. Key Market Challenges & Risks of Cryptococcosis Drugs
Table 42. Key Industry Trends of Cryptococcosis Drugs
Table 43. Global Cryptococcosis Drugs Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Cryptococcosis Drugs Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Cryptococcosis Drugs Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Cryptococcosis Drugs Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Abbott Details, Company Type, Cryptococcosis Drugs Area Served and Its Competitors
Table 48. Abbott Cryptococcosis Drugs Product Offered
Table 49. Abbott Cryptococcosis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Abbott Main Business
Table 51. Abbott Latest Developments
Table 52. Pfizer Details, Company Type, Cryptococcosis Drugs Area Served and Its Competitors
Table 53. Pfizer Cryptococcosis Drugs Product Offered
Table 54. Pfizer Cryptococcosis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Bristol-Mayers Squibb Details, Company Type, Cryptococcosis Drugs Area Served and Its Competitors
Table 58. Bristol-Mayers Squibb Cryptococcosis Drugs Product Offered
Table 59. Bristol-Mayers Squibb Cryptococcosis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Bristol-Mayers Squibb Main Business
Table 61. Bristol-Mayers Squibb Latest Developments
Table 62. Sigmapharm Laboratories Details, Company Type, Cryptococcosis Drugs Area Served and Its Competitors
Table 63. Sigmapharm Laboratories Cryptococcosis Drugs Product Offered
Table 64. Sigmapharm Laboratories Cryptococcosis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Sigmapharm Laboratories Main Business
Table 66. Sigmapharm Laboratories Latest Developments
Table 67. Novartis Details, Company Type, Cryptococcosis Drugs Area Served and Its Competitors
Table 68. Novartis Cryptococcosis Drugs Product Offered
Table 69. Novartis Cryptococcosis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Novartis Main Business
Table 71. Novartis Latest Developments
Table 72. Glenmark Pharmaceuticals Details, Company Type, Cryptococcosis Drugs Area Served and Its Competitors
Table 73. Glenmark Pharmaceuticals Cryptococcosis Drugs Product Offered
Table 74. Glenmark Pharmaceuticals Cryptococcosis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Glenmark Pharmaceuticals Main Business
Table 76. Glenmark Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cryptococcosis Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cryptococcosis Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Cryptococcosis Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Cryptococcosis Drugs Sales Market Share by Country/Region (2024)
Figure 8. Cryptococcosis Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Cryptococcosis Drugs Market Size Market Share by Type in 2024
Figure 10. Cryptococcosis Drugs in Hospital Pharmacy
Figure 11. Global Cryptococcosis Drugs Market: Hospital Pharmacy (2020-2025) & ($ millions)
Figure 12. Cryptococcosis Drugs in Retail Pharmacies
Figure 13. Global Cryptococcosis Drugs Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 14. Cryptococcosis Drugs in Other
Figure 15. Global Cryptococcosis Drugs Market: Other (2020-2025) & ($ millions)
Figure 16. Global Cryptococcosis Drugs Market Size Market Share by Application in 2024
Figure 17. Global Cryptococcosis Drugs Revenue Market Share by Player in 2024
Figure 18. Global Cryptococcosis Drugs Market Size Market Share by Region (2020-2025)
Figure 19. Americas Cryptococcosis Drugs Market Size 2020-2025 ($ millions)
Figure 20. APAC Cryptococcosis Drugs Market Size 2020-2025 ($ millions)
Figure 21. Europe Cryptococcosis Drugs Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Cryptococcosis Drugs Market Size 2020-2025 ($ millions)
Figure 23. Americas Cryptococcosis Drugs Value Market Share by Country in 2024
Figure 24. United States Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Cryptococcosis Drugs Market Size Market Share by Region in 2024
Figure 29. APAC Cryptococcosis Drugs Market Size Market Share by Type (2020-2025)
Figure 30. APAC Cryptococcosis Drugs Market Size Market Share by Application (2020-2025)
Figure 31. China Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 35. India Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Cryptococcosis Drugs Market Size Market Share by Country in 2024
Figure 38. Europe Cryptococcosis Drugs Market Size Market Share by Type (2020-2025)
Figure 39. Europe Cryptococcosis Drugs Market Size Market Share by Application (2020-2025)
Figure 40. Germany Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 41. France Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Cryptococcosis Drugs Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Cryptococcosis Drugs Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Cryptococcosis Drugs Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Cryptococcosis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 54. APAC Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 55. Europe Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 57. United States Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 58. Canada Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 59. Mexico Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 60. Brazil Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 61. China Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 62. Japan Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 63. Korea Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 65. India Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 66. Australia Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 67. Germany Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 68. France Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 69. UK Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 70. Italy Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 71. Russia Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 72. Egypt Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 73. South Africa Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 74. Israel Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 75. Turkey Cryptococcosis Drugs Market Size 2026-2031 ($ millions)
Figure 76. Global Cryptococcosis Drugs Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Cryptococcosis Drugs Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Cryptococcosis Drugs Market Size 2026-2031 ($ millions)